A Study to Evaluate the Effect of ACP-196 on the Heart Rate-corrected QT Interval in Healthy Adult Participants
Clinical trial NCT04867980 · COMPLETED
Trial details
- NCT number
- NCT04867980
- Sponsor
- Acerta Pharma BV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2016-05-09
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.